Epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer: impact of primary or secondary mutations (Q36501738)
scientific article published on May 2006
Language:
Current Data About Epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer: impact of primary or secondary mutations
(P31) (Q13442814)
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P50) (Q47492209)
(P1545) 3
(P1932) Ming-Sound Tsao
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P304) S138-44
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P407) (Q1860)

(P478) 7 Suppl 4
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P577) Monday, May 1, 2006
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P921) (Q47912)
(P887)

(P1433) (Q332299)
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P1476) "Epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer: impact of primary or secondary mutations" (language: en)
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P2093) Akira Sakurada
(P1545) 1
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

Frances A Shepherd
(P1545) 2
(P248)
(P698) 16764754
(P813) Monday, August 14, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article published on May 2006

External Links
(P356) 10.3816/CLC.2006.S.005
(P698) 16764754